Is a complete VBIO research report available?

No complete published report is available for Valion Bio, Inc. (VBIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Valion Bio, Inc. (VBIO)

NASDAQ: VBIO · USD

$0.69

-0.09 (-12.1%)· Recorded snapshot

Market cap	610.4K
Net income (ttm)	-19.2M
EPS (ttm)	-$210
Shares out	887.6K
Volume	517,034
Beta	1.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -19.2M
EPS (ttm): -$210
Market cap: 610.4K

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Metric	Value
Amount currency	USD
CIK code	0001787740
Company name	Valion Bio, Inc.
Country	United States
Country code	US
CUSIP number	918942202
Earnings date	2026-11-13
Earnings time	amc
Employees	52
Employees change	45
Employees growth	642.86%
Enterprise value	$15.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
Industry	Biotechnology
IPO date	2021-11-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US9189422028
Last 10-K release date	2026-03-30
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-08-31
Last stock split type	Reverse
Market cap	$610,395
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$0.69
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	VBIO
U.S. state	Texas
Website	https://valionbio.com

Metric

Value

Amount currency

USD

CIK code

0001787740

Company name

Valion Bio, Inc.

Country

United States

Country code

CUSIP number

918942202

Earnings date

2026-11-13

Earnings time

amc

Employees

Employees change

Employees growth

642.86%

Enterprise value

$15.9M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2016

Industry

Biotechnology

IPO date

2021-11-11

Is primary listing

Yes

Is SPAC

ISIN number

US9189422028

Last 10-K release date

2026-03-30

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-08-31

Last stock split type

Reverse

Market cap

$610,395

Market cap category

Nano-Cap

Next earnings date

2026-11-13

Options

Price

$0.69

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

VBIO

U.S. state

Texas

Website

https://valionbio.com

Metric	Value
Earnings yield	-30,565.42%
FCF / EV yield	-91.74%
FCF yield	-2,114.39%
P/B ratio	0.03x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-30,565.42%

FCF / EV yield

-91.74%

FCF yield

-2,114.39%

P/B ratio

0.03x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-369,808
ROA	-57.13%
ROA (5Y)	-59.05%
ROCE	-57.43%
ROE	-459.52%
ROE (5Y)	-143.5%
ROIC	-83.36%

Metric

Value

Profit per employee

$-369,808

ROA

-57.13%

ROA (5Y)

-59.05%

ROCE

-57.43%

ROE

-459.52%

ROE (5Y)

-143.5%

ROIC

-83.36%

Metric	Value
EPS growth quarters	6
EPS growth years	4
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-99,000
Depreciation and amortization	$365,000
EBIT	$-16.9M
EBITDA	$-16.5M
EPS	$-210.20
FCF per share	$-16.53
Financing cash flow	$16.1M
Free cash flow	$-14.7M
Free cash flow minus SBC	$-15.3M
Investing cash flow	$-223,000
Net cash flow	$1.3M
Net income	$-19.2M
Operating cash flow minus SBC	$-15.2M
Operating income	$-16.9M
Stock-based compensation	$629,000

Metric

Value

Capital expenditures

$-99,000

Depreciation and amortization

$365,000

EBIT

$-16.9M

EBITDA

$-16.5M

EPS

$-210.20

FCF per share

$-16.53

Financing cash flow

$16.1M

Free cash flow

$-14.7M

Free cash flow minus SBC

$-15.3M

Investing cash flow

$-223,000

Net cash flow

$1.3M

Net income

$-19.2M

Operating cash flow minus SBC

$-15.2M

Operating income

$-16.9M

Stock-based compensation

$629,000

Metric	Value
Book value per share	$25.57
Debt / equity	4.1
Goodwill	$3.5M
Interest coverage	-11.38
Long-term assets	$29.1M
Long-term liabilities	$25.2M
Net cash (debt)	$-15.3M
Net cash / market cap	-2,204.74%
Net debt / equity	3.6
Piotroski F-Score	1
Property, plant and equipment	$22.2M
Shareholders' equity	$4.2M
Tangible book value	$-1.5M
Tangible book value per share	$-8.75
Total assets	$32.5M
Total cash	$2.1M
Total debt	$17.4M
Total liabilities	$28.2M
WACC	7.02%

Metric

Value

Book value per share

$25.57

Debt / equity

4.1

Goodwill

$3.5M

Interest coverage

-11.38

Long-term assets

$29.1M

Long-term liabilities

$25.2M

Net cash (debt)

$-15.3M

Net cash / market cap

-2,204.74%

Net debt / equity

3.6

Piotroski F-Score

Property, plant and equipment

$22.2M

Shareholders' equity

$4.2M

Tangible book value

$-1.5M

Tangible book value per share

$-8.75

Total assets

$32.5M

Total cash

$2.1M

Total debt

$17.4M

Total liabilities

$28.2M

WACC

7.02%

Metric	Value
Current assets	$3.4M
Current liabilities	$3M
Current ratio	1.11
Net working capital	$-1.2M
Quick ratio	0.69
Working capital	$336,000

Metric

Value

Current assets

$3.4M

Current liabilities

$3M

Current ratio

1.11

Net working capital

$-1.2M

Quick ratio

0.69

Working capital

$336,000

Metric	Value
Buyback yield / dilution	-296.62%
Dividend yield	0%
Shareholder yield	-296.62%

Metric

Value

Buyback yield / dilution

-296.62%

Dividend yield

Shareholder yield

-296.62%

Metric	Value
150-day SMA	$12.37
1D price change	-12.05%
1M price change	-77.51%
1M total return	-77.51%
1W price change	-42.74%
1W total return	-42.74%
1Y price change	-99.03%
1Y return CAGR	-99.03%
1Y total return	-99.03%
20-day SMA	$1.56
200-day SMA	$15.40
3M price change	-90.36%
3M total return	-90.36%
3Y price change	-99.88%
3Y return CAGR	-89.24%
3Y total return	-99.88%
50-day SMA	$2.33
50-day SMA vs 200-day SMA	50under200
52-week high	$70.00
52-week high date	2025-10-28
52-week low	$0.66
52-week low date	2026-10-28
6M price change	-98.05%
6M total return	-98.05%
All-time high	$276,250.14
All-time high date	2021-11-11
All-time low	$0.66
All-time low date	2026-10-28
Average true range (ATR)	$0.35
Average volume	1.8M
Beta (1Y)	2.8
Beta (2Y)	2.4
Beta (5Y)	1.8
Change from 52-week high	-99.02%
Change from 52-week low	3.66%
Change from all-time high	-100%
Change from all-time low	0%
Change from open	-8.11%
Day's gap	-4.28%
Dollar volume	$355,564
High price	$0.76
Low price	$0.67
Monthly RSI	25.36
Open price	$0.75
Position in 52-week range	17.96%
Premarket change	-2.81%
Premarket close	$0.78
Premarket price	$0.76
Premarket volume	308K
Previous close	$0.78
Price vs 150-day SMA	-94.49%
Price vs 20-day SMA	-56.38%
Price vs 200-day SMA	-95.58%
Price vs 50-day SMA	-70.78%
Relative volume	0.29
Return from IPO open	-100%
RSI	21.52
Sharpe ratio	-2.77
Sharpe ratio (3Y)	-0.45
Sortino ratio	-3.43
Sortino ratio (3Y)	-0.89
Volume	517K
Weekly RSI	22.76
YTD price change	-98.12%
YTD total return	-98.12%

Metric

Value

150-day SMA

$12.37

1D price change

-12.05%

1M price change

-77.51%

1M total return

-77.51%

1W price change

-42.74%

1W total return

-42.74%

1Y price change

-99.03%

1Y return CAGR

-99.03%

1Y total return

-99.03%

20-day SMA

$1.56

200-day SMA

$15.40

3M price change

-90.36%

3M total return

-90.36%

3Y price change

-99.88%

3Y return CAGR

-89.24%

3Y total return

-99.88%

50-day SMA

$2.33

50-day SMA vs 200-day SMA

50under200

52-week high

$70.00

52-week high date

2025-10-28

52-week low

$0.66

52-week low date

2026-10-28

6M price change

-98.05%

6M total return

-98.05%

All-time high

$276,250.14

All-time high date

2021-11-11

All-time low

$0.66

All-time low date

2026-10-28

Average true range (ATR)

$0.35

Average volume

1.8M

Beta (1Y)

2.8

Beta (2Y)

2.4

Beta (5Y)

1.8

Change from 52-week high

-99.02%

Change from 52-week low

3.66%

Change from all-time high

-100%

Change from all-time low

Change from open

-8.11%

Day's gap

-4.28%

Dollar volume

$355,564

High price

$0.76

Low price

$0.67

Monthly RSI

25.36

Open price

$0.75

Position in 52-week range

17.96%

Premarket change

-2.81%

Premarket close

$0.78

Premarket price

$0.76

Premarket volume

308K

Previous close

$0.78

Price vs 150-day SMA

-94.49%

Price vs 20-day SMA

-56.38%

Price vs 200-day SMA

-95.58%

Price vs 50-day SMA

-70.78%

Relative volume

0.29

Return from IPO open

-100%

RSI

21.52

Sharpe ratio

-2.77

Sharpe ratio (3Y)

-0.45

Sortino ratio

-3.43

Sortino ratio (3Y)

-0.89

Volume

517K

Weekly RSI

22.76

YTD price change

-98.12%

YTD total return

-98.12%

Metric	Value
Float	879.6K
Float percentage	99.1%
Shares change (QoQ)	17.21%
Shares change (YoY)	296.62%
Shares held by insiders	0.63%
Shares held by institutions	14.18%
Shares outstanding	887.6K
Short % of float	10%
Short % of shares	9.91%
Short ratio	0 days

Metric

Value

Float

879.6K

Float percentage

99.1%

Shares change (QoQ)

17.21%

Shares change (YoY)

296.62%

Shares held by insiders

0.63%

Shares held by institutions

14.18%

Shares outstanding

887.6K

Short % of float

10%

Short % of shares

9.91%

Short ratio

0 days

Valion Bio, Inc. (VBIO)

Price

Financial snapshot

Fair-value bridge

Latest news · VBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VBIO

Frequently asked questions